We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Fig 3.

Fig 3. From: Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer.

Adjusted odds of receiving chemotherapy for each institution over time. The referent group for all odds ratios is institution D during the 1997 to 1998 period.

Michael J. Hassett, et al. J Clin Oncol. 2008 December 1;26(34):5553-5560.
2.
Fig 2.

Fig 2. From: Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer.

Percentage of patients receiving chemotherapy by age at diagnosis, tumor size, and institution for each year of diagnosis. P values refer to analyses of unadjusted relationships between receipt of chemotherapy and age, tumor size, or institution using the Mantel-Haenszel χ2 test for trend.

Michael J. Hassett, et al. J Clin Oncol. 2008 December 1;26(34):5553-5560.
3.
Fig 1.

Fig 1. From: Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer.

Percentage of patients receiving chemotherapy at each institution stratified by age at diagnosis. P values refer to analyses of unadjusted relationships between institution and receipt of chemotherapy for each age stratum using the χ2 test.

Michael J. Hassett, et al. J Clin Oncol. 2008 December 1;26(34):5553-5560.

Supplemental Content

Recent activity

Your browsing activity is temporarily unavailable.

Write to the Help Desk